The description of the histological features and the immunohistochemical and molecular analyses of a case of cribriform-morular variant of papillary thyroid carcinoma in an 8-year-old girl with a family history of adenomatous polyposis is presented. The neoplasm was multifocal and bilateral, with a mixed pattern of solid, trabecular, and morular areas. The neoplasm showed angioinvasive behavior, extracapsular infiltration with extension to the perythyroidal muscles, and lymph node metastases. Tumor cells were positive for CAM 5.2, cytokeratins 5/6, TTF-1, HBME-1, galectin-3, and β-catenin. In addition, the molecular tests did not reveal BRAF mutations, RET/PTC rearrangement, APC mutation, or KRAS mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896912441830DOI Listing

Publication Analysis

Top Keywords

cribriform-morular variant
8
variant papillary
8
papillary thyroid
8
thyroid carcinoma
8
carcinoma 8-year-old
8
8-year-old girl
8
immunohistochemical molecular
8
girl case
4
case report
4
report immunohistochemical
4

Similar Publications

Article Synopsis
  • The 5th edition of the WHO classification of thyroid tumors reflects significant updates, particularly in molecular biology, influencing how traditional conditions are categorized and named.
  • Terms have been modernized, such as referring to Hürthle cells as oncocytes, and new subtypes for follicular adenoma and non-invasive follicular thyroid neoplasm with papillary-like features (NIFTP) have emerged.
  • A multidisciplinary treatment approach has led to the introduction of grading systems for various thyroid carcinomas, along with new classifications for rare tumors, including salivary gland-type carcinomas.
View Article and Find Full Text PDF

Background/objective: Cribriform-morular thyroid carcinoma (CMTC) was considered a variant of papillary thyroid carcinoma (PTC) but is a separate entity in the 2022 World Health Organization classification. CMTC has an association with familial adenomatous polyposis (FAP). Our objective is to report a case of CMTC who was subsequently diagnosed with FAP, to highlight these associated entities and implications for management.

View Article and Find Full Text PDF

Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC) have been performed before the 2017 World Health Organization (WHO) classification, in which the diagnostic criteria of follicular variants of PTC have been modified and noninvasive follicular thyroid neoplasm with papillary-like nuclear features has been introduced. This study aims to investigate the shift in the incidence of BRAF V600E mutations in PTCs following the 2017 WHO classification and to further characterize the histologic subtypes and molecular drivers in BRAF-negative cases. The study cohort consisted of 554 consecutive PTCs larger than 0.

View Article and Find Full Text PDF

The cribriform-morular variant of papillary thyroid carcinoma (CMV-PTC) is now designated as morular cribriform thyroid carcinoma (CMTC) according to the 5 edition of the World Health Organization (WHO) Classification of Thyroid Tumors. CMTC can appear within a familial adenomatous polyposis (FAP) or be sporadic. We report the first case of a young female patient in China who was diagnosed with FAP and CMTC with a mutation in exon 16 of the APC gene underlying the disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!